Anne-Sophie Bessis,Beatrice Bonnet,Emmanuel Le Poul,Jean-Philippe Rocher,Mark Epping-Jordan
申请号:
US13251197
公开号:
US08163775B2
申请日:
2011.09.30
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The present invention relates to new compounds of formula (I) wherein A, B, P, Q, W, R1 and R2 are defined in the description invention compounds are useful in the prevention or treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.